Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
European Journal of Medicinal Chemistry
|
April 6, 2022
Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors
Qiuping Xiang, Guolong Luo, Cheng Zhang, et al.
Journal of Medicinal Chemistry
|
June 14, 2021
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist
Xishan Wu, Hui Shen, Yan Zhang, et al.
Environment International
|
April 20, 2021
Correspondence between DOM molecules and microbial community in a subtropical coastal estuary on a spatiotemporal scale
Qi Chen, Feng Chen, Michael Gonsior, et al.
The Science of the Total Environment
|
April 3, 2024
Heavy metal induced shifts in microbial community composition and interactions with dissolved organic matter in coastal sediments
Yu Wang, Yuxing Hu, Yanting Liu, et al.
Thoracic Cancer
|
March 4, 2025
Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis
Hui Xu, Zhinuan Hong, Ye Lin, et al.
Journal of Medicinal Chemistry
|
January 2, 2025
Discovery of a Potent and Selective GSPT1 Molecular Glue Degrader for the Treatment of Castration-Resistant Prostate Cancer
Hui Shen, Hongrui Xu, Weiqin Jin, et al.
Hepatology (Baltimore, Md.)
|
August 1, 2018
DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera
Pengfei Pang, Xiaojun Hu, Bin Zhou, et al.
Alimentary Pharmacology & Therapeutics
|
July 3, 2026
Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine
Yule Ma, Huigang Li, Huan Chen, et al.
Journal of Medicinal Chemistry
|
April 10, 2019
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang, Xishan Wu, Xiaoqian Xue, et al.
European Journal of Medicinal Chemistry
|
February 20, 2026
Discovery of novel indole derivatives as LRH-1 antagonists for the treatment of castration resistant prostate cancer
Kaiyuan Ma, Weiqin Jin, Yan Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
European Journal of Medicinal Chemistry
|
April 6, 2022
Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors
Qiuping Xiang, Guolong Luo, Cheng Zhang, et al.
Journal of Medicinal Chemistry
|
June 14, 2021
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist
Xishan Wu, Hui Shen, Yan Zhang, et al.
Environment International
|
April 20, 2021
Correspondence between DOM molecules and microbial community in a subtropical coastal estuary on a spatiotemporal scale
Qi Chen, Feng Chen, Michael Gonsior, et al.
The Science of the Total Environment
|
April 3, 2024
Heavy metal induced shifts in microbial community composition and interactions with dissolved organic matter in coastal sediments
Yu Wang, Yuxing Hu, Yanting Liu, et al.
Thoracic Cancer
|
March 4, 2025
Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis
Hui Xu, Zhinuan Hong, Ye Lin, et al.
Journal of Medicinal Chemistry
|
January 2, 2025
Discovery of a Potent and Selective GSPT1 Molecular Glue Degrader for the Treatment of Castration-Resistant Prostate Cancer
Hui Shen, Hongrui Xu, Weiqin Jin, et al.
Hepatology (Baltimore, Md.)
|
August 1, 2018
DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera
Pengfei Pang, Xiaojun Hu, Bin Zhou, et al.
Alimentary Pharmacology & Therapeutics
|
July 3, 2026
Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine
Yule Ma, Huigang Li, Huan Chen, et al.
Journal of Medicinal Chemistry
|
April 10, 2019
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang, Xishan Wu, Xiaoqian Xue, et al.
European Journal of Medicinal Chemistry
|
February 20, 2026
Discovery of novel indole derivatives as LRH-1 antagonists for the treatment of castration resistant prostate cancer
Kaiyuan Ma, Weiqin Jin, Yan Zhang, et al.
Page
of 8